Man Faints in Oval Office as Trump Admin Announces Price Cuts in Weight-Loss Drugs

Novo Nordisk denied reports that the man who fainted was the company’s Global Brand Director Gordon Findlay.
Man Faints in Oval Office as Trump Admin Announces Price Cuts in Weight-Loss Drugs
President Donald Trump looks on after a man fainted during an announcement about weight-loss drugs in the Oval Office of the White House on Nov. 6, 2025. Andrew Caballero-Reynolds/AFP via Getty Images
|Updated:
0:00
A man fainted in the Oval Office on Nov. 6 as the Trump administration announced sweeping price cuts to popular GLP-1 weight loss drugs, such as Ozempic and Wegovy, starting in early 2026.

Eli Lilly CEO David A. Ricks was speaking about the deal when an unidentified man behind him, wearing a black suit, white shirt, and gray tie, started to sway back and forth.

Jacki Thrapp
Jacki Thrapp
Author
Jacki Thrapp is an Emmy® Award-winning journalist based in Nashville. She previously worked at The New York Post, Fox News Channel and has written a series of Off-Broadway musicals in NYC. Contact her at [email protected]